Table of Contents Table of Contents
Previous Page  164 / 227 Next Page
Information
Show Menu
Previous Page 164 / 227 Next Page
Page Background

1$785$/ 5(0(',(6

3DJH RI

1.2] SUMMARY REPORT OF VALIDATION:

Accuracy

Acceptance criterion for recovery:

75 to 125% for assay > 0.1 and < 0.5%.

85 to 120% for assay > 0.1 and < 0.5%.

70 to 130% for assay < 0.1%.

Compound

Recovery

Specificity

Very specific for Withanoside IV, Withanoside V,

Withaferin

A,

12-Deoxy

Withastramonolide,

Withanolide A & Withanolide B with no interference

from other compounds. Confirmed by the PDA spectra

and the peak purity.

Peak purity > 0.98

Withanoside IV

94.6 to 101.8%

Withanoside V

95.3 to 101.2%

Withaferin A RSD

95.9 to 100.7%

12-Deoxy

Withastramonolide

91.2 to 101.6%

Withanolide A

93.7 to 99.6%

Ruggedness

One sample, 2 different HPLC columns, 2 different

conditions and 2 different instruments

Acceptance criterion: RSD = < 6.0%

Actual RSD% = 5.0%

Withanolide B

74.0 to 106.0%

Precision (of Concentration, Retention time and Reproducibility)

7 concentrations of each, 5 replicates of each

Acceptance criterion: RSD = < 2.5%

RSD

Compound

Retention time

Peak area

Withanoside IV

0.62

0.5%

Withanoside V

0.55

0.86%

Withaferin A

0.49

0.5%

12-Deoxy Withastramonolide

0.38

0.6%

Withanolide A

0.34

1.5%

Withanolide B

0.21

0.9%

Range of quantification

The following limits are considered as a better working

range based on linearity and closeness (within ± 5%)

to mean response factor.

Compound

Concentration

(mcg/ml)

Withanoside IV

20.64 – 330.3

Withanoside V

18.76 – 300.15

Withaferin A

23.05 – 184.39

12-Deoxy

Withastramonolide

22.21 – 177.65

Withanolide A

21.59 – 172.76

Withanolide B

21.09 – 168.79

Stability of Sample & Standard Solutions

Sample solution tested after 24 hrs. The

variation in assay found to be + 3.2%

The solution is stable for 24 hours.

Standard solution is also stable for 24 hours.

Linearity

7 concentrations of each, 5 replicates of each

Acceptance criterion: Correlation coefficient (r

2

) for all

compounds to be >0.98

Compound

r

2

Concentration

range(mcg/ml)

Withanoside IV

0.999

20.0 to 1321

Withanoside V

0.999

18.7 to 1200

Withaferin A

0.996

23.0 to 737

12-Deoxy

Withastramonolide

0.990

22.0 to 355

Withanolide A

0.992

21.0 to 345

Withanolide B

0.984

21.0 to 337

System suitability

1) The resolution is >3 for Withanoside V and

Withaferin A in the standard mix.

2) The asymmetric factor (tailing factor) should

be < 1.5

3) The precision of injection (with minimum of 3

replicates) RSD should be < 2.5%.

4) Relative retention time of

Withanoside IV

-

0.7

Withanoside V

-

0.89

Withaferin A

-

0.92

12-Deoxy Withastramonolide -

0.96

Withanolide A

-

1.0

Withanolide B

-

1.15

Conclusion:

The HPLC method [NR/QCD/APM04 WI(17)] for the estimation of

Withania

somnifera

is validated.